bilastine: Clinical Trials

6 trials of bilastine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Unknown 2
Phase 21Completed 1

Follow bilastine: new trials by email Literature Review of bilastine trials Research Report on bilastine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions
Bilastine oral dispersible tablets, Bilaxten oral dispersible tablets - Allergic Rhino-Conjunctivitis, Urticaria
Phase 1CompletedHumanis Saglık Anonim Sirketi422025-04-302025-06-29
Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects
Test (T) Bilastine, Reference (R) Bilastine - Healthy
Phase 1UnknownThe Affiliated Hospital of Qingdao University402023-11-212023-10-24
Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese Population
Bilastine 40mg single dose, Bilastine 20mg single-dose followed by multiple-dose - Pharmacokinetics
Phase 1UnknownA.Menarini Asia-Pacific Holdings Pte Ltd242018-08-282019-01-10
Oral Bioavailability of Bilastine
Bilastine - Healthy
Phase 1CompletedFaes Farma, S.A.122010-05-012012-09-26
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria
Phase 1 / Phase 2CompletedFaes Farma, S.A.362010-01-012012-09-26
A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine
bilastine, Bilastine, Bilastine & Ketoconazole - Healthy
Phase 1CompletedFaes Farma, S.A.302006-08-012012-04-05

Conditions studied

Urticaria (3)  ·  Rhinitis, Allergic (2)  ·  Chronic Urticaria (1)  ·  Erythema (1)  ·  Hypersensitivity (1)  ·  Nasal Obstruction (1)  ·  Pruritus (1)  ·  Rhinitis, Allergic, Perennial (1)  ·  Rhinitis, Allergic, Seasonal (1)  ·  Rhinorrhea (1)  ·  Sneezing (1)

Sponsors

Faes Farma, S.A. (3)  ·  A.Menarini Asia-Pacific Holdings Pte Ltd (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  The Affiliated Hospital of Qingdao University (1)

Countries

Australia (1)  ·  China (1)  ·  Germany (1)  ·  India (1)  ·  Spain (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Andrea Luk, Professor (1)  ·  Belen Sadaba, MD (1)  ·  Gunilla Hedlin, Prof. Dr. (1)  ·  Lennart Nordvall, Prof. Dr (1)  ·  Mark J Allison, MD (1)  ·  Noel E Cranswick, Prof. Dr. (1)  ·  Peter Le Souef, Prof. Dr. (1)  ·  Stefan Zielen, Prof. Dr. (1)  ·  Ulrich Wahn, Prof. Dr. (1)

Results publications

PMID 21642470, PMID 22393898, PMID 23529786

NIH funding

2009 (1)